全球农村及偏远地区类风湿关节炎患者的系统综述
在有城市对照的研究中,农村及偏远人群的RA患病风险未增加,疾病活动度和残疾无显著差异,但诊断时间、随访、专科服务可及性和药物使用方面存在更大障碍。
要点
- 农村及偏远地区RA患病风险与城市相比无一致升高证据
- 疾病活动度和残疾程度在城市对照研究中无显著差异
- 农村及偏远地区患者面临诊断延迟、随访和药物可及性障碍
核心结论
- 农村及偏远地区与城市人群的RA流行病学和临床结局不一定存在差异。
- 农村及偏远患者面临更大照护障碍,增加结局不平等的风险。
研究设计与样本
- 系统综述,检索Medline、Embase、HealthStar、CINAHL和Cochrane Library从建库至2019年6月。
主要发现
- 11项有合适城市对照的研究中,农村及偏远人群未显示RA风险增加,1项报告患病率升高,5项报告患病率降低。
- 有城市对照的研究显示疾病活动度或残疾无显著差异,但1项研究报告农村及偏远人群躯体功能和健康相关生活质量更差。
- 农村及偏远居住对诊断时间、持续随访、RA相关从业者和服务可及性、药物可及性和使用变异产生不利影响,国家间异质性显著。
临床怎么用
- 临床应关注农村及偏远RA患者在诊断延迟、随访和药物可及性方面的障碍。
- 针对农村及偏远患者需优化卫生服务可及性以减少结局不平等。
局限性
- 研究间存在显著异质性,尤其在国家间卫生服务使用方面。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rural and remote patients with rheumatoid arthritis (RA) are at risk for inequities in health outcomes based on differences in physical environments and health care access potential compared to urban populations. The aim of this systematic review was to synthesize epidemiology, clinical outcomes, and health service use reported for global populations with RA residing in rural and remote locations. METHODS: Medline, Embase, HealthStar, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and the Cochrane Library were searched from inception to June 2019 using librarian-developed search terms for RA and rural and remote populations. Peer-reviewed published manuscripts were included if they reported on epidemiologic, clinical, or health service use outcomes. RESULTS: Fifty-four articles were included for data synthesis, representing studies from all continents. In 11 studies in which there was an appropriate urban population comparator, rural and remote populations were not at increased risk for RA; 1 study reported increased prevalence, and 5 studies reported decreased prevalence in rural and remote populations. Clinical characteristics of rural and remote populations in studies with an appropriate urban comparator showed no significant differences in disease activity measures or disability, but 1 study reported worse physical function and health-related quality of life in rural and remote populations. Studies reporting on health service use provided evidence that rural and remote residence adversely impacts diagnostic time, ongoing follow-up, access to RA-care-related practitioners and services, and variation in medication access and use, with prominent heterogeneity noted between countries. CONCLUSION: RA epidemiology and clinical outcomes are not necessarily different between rural/remote and urban populations within countries. Rural and remote patients face greater barriers to care, which increases the risk for inequities in outcomes.
引用
- Pianarosa E, Chomistek K, Hsiao R, et al. Global Rural and Remote Patients With Rheumatoid Arthritis: A Systematic Review. Arthritis Care Res (Hoboken). 2022. PMID: 33181001. doi:10.1002/acr.24513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。